HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of penile cancer treated with combination of chemotherapy, radiation and radical operation].

Abstract
A 60-year-old [correction of 68] male was referred to our hospital because of a penile tumor with necrosis. Pathological examination of the penile tumor and superficial inguinal lymph nodes in biopsy revealed well differentiated squamous cell carcinoma (SCC) and the SCC tumor marker was elevated. TNM classification was T2, N2, M0 according to findings obtained by computed tomography (CT) and magnetic resonance imaging (MRI). We diagnosed the tumor inoperable radically and administered 10 mg peplomycin once a week for 10 weeks intravenously. The SCC marker level was not reduced and the tumor was not changed on MRI. Then, we performed combined pirarubicin treatment and radiotherapy. The patient received linac radiotherapy between 40 Gy/4 weeks/20 fractions. Pirarubicin, 10 mg/m2, was administered once a week for 4 weeks during irradiation intravenously. After the combined therapy, the SCC marked level was reduced to the normal range and the tumor was reduced. We performed radical operation. Pathological diagnosis revealed no viable tumor cells. The patient was alive with no evidence of disease a year later. This combined therapy is suggested to be useful.
AuthorsH Igarashi, Y Oishi, K Kishimoto, S Yanada, N Kondo, N Hasegawa
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 42 Issue 6 Pg. 465-7 (Jun 1996) ISSN: 0018-1994 [Print] Japan
PMID8741305 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Doxorubicin
  • pirarubicin
Topics
  • Antibiotics, Antineoplastic (administration & dosage)
  • Carcinoma, Squamous Cell (therapy)
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage, analogs & derivatives)
  • Humans
  • Male
  • Middle Aged
  • Penile Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: